Jagsonpal Pharmaceuticals Limited (NSEI: JAGSNPHARM)
Health Care · Pharmaceuticals · IN
Rs231.73
-4.36% today · +4.7% 1Y
Jagsonpal Pharmaceuticals Limited (NSEI: JAGSNPHARM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $158.68M and employs 1,297 people.
Over the last twelve months the share price has gained 4.7%, trading between 155.00 and 264.50.
Tweenvest scores Jagsonpal Pharmaceuticals Limited across four factors: quality 81/100, value 42/100, growth 40/100, dividend 45/100. Its strongest factor is quality.
JAGSNPHARM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $158.68M
- Revenue (TTM)
- $31.08M
- P/E
- 34.57
- EPS
- 6.70
- Dividend yield
- 1.08%
- Beta (5Y)
- -0.27
- 52-week high
- Rs264.50
- 52-week low
- Rs155.00
- Avg volume (3M)
- —
- Shares outstanding
- 65.93M
- Employees
- 1,297
- Next earnings
- —
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited, an Indian company founded in 1964 and based in New Delhi, specializes in the development and manufacturing of both bulk active pharmaceutical ingredients and diverse medicinal formulations. Its product portfolio spans three primary therapeutic domains: women's health, pain management and analgesia, and general medical care. Within general medicine, the company offers solutions for allergy control, immune and cellular protection, gastrointestinal and mental wellness, anti-infectives, and products specifically for dental and ear, nose, and throat (ENT) conditions. For women's healthcare, their offerings include pregnancy support and treatments for issues related to dysfunctional uterine bleeding. Furthermore, Jagsonpal provides medications for pain relief and skeletal and joint health. These pharmaceutical items are supplied in common forms like tablets, capsules, and syrups. The company operates as a subsidiary under Aresko Progressive Private Limited.
- ISIN
- INE048B01035
- Founded
- 1978
- Listed since
- Jul 1, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fermenta Biotech LimitedBSE: 506414 | $164.18M | Rs551.35 | +17.77% |
| TerrAscend Corp.TSX: TSND | $162.66M | CA$0.69 | -8.00% |
| Mayne Pharma Group LimitedASX: MYX | $162.21M | AU$2.85 | +1.42% |
| DAE HWA Pharmaceutical Co., Ltd.KOSDAQ: A067080 | $158.81M | ₩11,610.00 | +1.40% |
| Societe de Promotion Pharmaceutique du Maghreb S.A.CBSE: PRO | $155.42M | MAD— | — |
| Cenra Inc.TWSE: 3716 | $155.04M | NT$33.90 | -0.15% |
| Amrutanjan Health Care LimitedBSE: 590006 | $154.28M | Rs513.80 | +1.51% |
| AGP LimitedKASE: AGP | $152.79M | PKRs151.80 | -4.38% |
Figures last refreshed Oct 4, 2026.